Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
06/13/1996 | CA2204994A1 A method for enhancing outflow of aqueous humor in treatment of glaucoma |
06/13/1996 | CA2182904A1 Use of 2-[4-(azolylbutyl)piperazinyl-(methyl)]benzimidazole derivatives for preparing drugs for treating or preventing asthma |
06/12/1996 | EP0716093A1 Erythromycin derivatives, their process of preparation and application as medicaments |
06/12/1996 | EP0716087A1 Heterocyclic amides for control of the potassium channels |
06/12/1996 | EP0716086A1 Malonic acid based matrix metalloproteinase inhibitors |
06/12/1996 | EP0716085A1 Amino acid derivatives of paclitaxel |
06/12/1996 | EP0716083A1 Benzazepine derivative, pharmaceutical composition containing the same, and intermediate for the same |
06/12/1996 | EP0716082A1 Oxy-phenyl-(phenyl)glycinolamides substituted with a heterocycle having antiatherosclerotic activity |
06/12/1996 | EP0716081A1 Highly selective process for the preparation of enantiomerically pure phenyl-substituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives |
06/12/1996 | EP0716077A1 Aromatically substituted omega amino alcanoic acid amides and alcanoic diamides and their use as renine inhibitors |
06/12/1996 | EP0715856A1 Keratin-storable antifungal composition for external use |
06/12/1996 | EP0715855A2 NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis |
06/12/1996 | EP0715854A2 Carcinostatic compositions containing cis-oxalato and one or more other compatible carcinostatic substances |
06/12/1996 | EP0715853A1 Use of glutathione esters for the treatment of pulmonary diseases |
06/12/1996 | EP0715852A1 Use of hyaluronic acid or its salt to treat skin disease |
06/12/1996 | EP0715851A2 Substituted phenylpyrimidine derivatives, useful in the treatment of prevention of CNS disorders |
06/12/1996 | EP0715850A1 Use of proline and/or derivatives as an antihepatitis agent |
06/12/1996 | EP0715849A1 A method of inhibiting endotoxin induced effects |
06/12/1996 | EP0715845A1 Self tanning cosmetic compositions containing dihydroxyacetone, alkylpolyosides and fatty alcohols |
06/12/1996 | EP0715844A1 Composition containing abrasive and detergent system |
06/12/1996 | EP0715632A1 Anti-sense oligonucleotides for aromatase inhibition |
06/12/1996 | EP0715628A1 Substituted azaindolylidene compounds and process for their preparation |
06/12/1996 | EP0715627A1 Indole derivatives as thromboxane a2 antagonists |
06/12/1996 | EP0715626A1 Antimicrobial quinolinyl-(1h-1,2,4-triazol-1-yl)alkanol derivatives |
06/12/1996 | EP0715624A1 Process for the preparation of benzodiazepine compounds useful as antagonists of cck or of gastrine |
06/12/1996 | EP0715623A1 Platelet aggregation inhibitors |
06/12/1996 | EP0715620A1 1-arylcycloalkyl sulphides, sulphoxides and sulphones for the treatment of depression, anxiety and parkinson's disease |
06/12/1996 | EP0715619A1 Inhibitors of tnf-alpha secretion |
06/12/1996 | EP0715613A1 New diphenylhexene |
06/12/1996 | EP0715523A1 Purine nucleoside phosphorylase gene therapy for human malignancy |
06/12/1996 | EP0715520A1 Antiacid pharmaceutical composition in the form of a suspension based on sucralphate gel |
06/12/1996 | EP0715519A1 Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose |
06/12/1996 | EP0715518A1 Agent for transdermal application containing gestoden esters |
06/12/1996 | EP0715517A1 Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
06/12/1996 | EP0715516A1 Oral compositions of h 2?-antagonists |
06/12/1996 | EP0619819B1 1-arylheteroarylalkyl substituted-1h-1,2,4-triazole compounds for treatment of circulatory disorders |
06/12/1996 | EP0618901B1 Highly water soluble bis-naphthalimides useful as anticancer agents |
06/12/1996 | EP0556322B1 Aminosulfonyl urea acat inhibitors |
06/12/1996 | EP0515420B1 Nitric acid esters of cyclohexanol derivatives |
06/12/1996 | EP0505454B1 Container for fan-folded sheets |
06/12/1996 | EP0498843B1 Oligonucleotide analogs with novel linkages |
06/12/1996 | EP0497820B1 Ribozyme inhibitors |
06/12/1996 | EP0495982B1 Bicyclic pyrimidine derivative, method of producing the same, and pharmaceutical preparation containing the same as active ingredient |
06/12/1996 | EP0451203B1 Modulation of adenylate cyclase response |
06/12/1996 | EP0422134B1 5-ht selective agents |
06/12/1996 | CN1124490A 4-amino-17beta-(cyclopropyloxy) androst-4-en-3-one, 4-amino-17beta-(cyclopropylamino)androst-4-en-3-one and related compounds as C17-20 lyase and 5alpha-reductase inhibitors |
06/12/1996 | CN1124489A Tetracyclic compounds as dopamine agonists |
06/12/1996 | CN1124488A New thiazolidindiones and drugs containing them |
06/12/1996 | CN1124486A Heterocycle-containing amidine derivatives, their preparation and use |
06/12/1996 | CN1124485A Novel 1-phenylalkanone 5-HT4 receptor ligands |
06/12/1996 | CN1124484A 3-(indol-3-YL) propenoic acid derivatives and as NMDA antagonists |
06/12/1996 | CN1124483A N-alkylthio polyamine derivatives as radioprotective agents |
06/12/1996 | CN1124454A Rectal compositions |
06/12/1996 | CN1124453A Broiler ascites preventive and method of preventing ascites |
06/12/1996 | CN1124451A Liquid antacid compositions |
06/12/1996 | CN1124450A Deodorant active-substance combinations made from wool-grease acids and partial glycerides |
06/12/1996 | CN1124251A Aza steroid preparation and its use |
06/12/1996 | CN1124250A 17-deoxycorticosteroid-21-|O¨-carboxylic esters, processes for their preparation and pharmaceuticals containing these compounds |
06/12/1996 | CN1124246A Tetrazole derivatives, their production and use |
06/12/1996 | CN1124162A Weight increasing agent for animals and poultry |
06/12/1996 | CN1124143A Powder preparation for healing damaged skin |
06/12/1996 | CN1124142A Oligonucleotides to inhibit the expression of isoprenyl protein transferases |
06/12/1996 | CN1124141A Xinmailong extract and Xinmailong medical preparation for curing angiocardiopath |
06/12/1996 | CN1124140A Pharmaceutical compositions permitting the prolonged release of trimetazidine after oral administration |
06/12/1996 | CN1124139A Diazoletan efferrescent tablets and preparing method thereof |
06/12/1996 | CN1124138A Compositions for treatment of diabetic complications |
06/12/1996 | CN1124137A Organic zinc salt compound for animal growth promoting agent |
06/12/1996 | CN1124135A Producing method for vascular embolism porcelain powder |
06/12/1996 | CN1032004C 13-alkyl-23-imino and 13-halo-23-imino derivatives of LL-F28249 compounds and their use |
06/12/1996 | CN1032000C Process for preparing pyrazolidinone CCK and gastrin antagonists |
06/12/1996 | CN1031999C Process for preparing 6-substituted-tetrahydrobenz |CD¨ indoles |
06/12/1996 | CN1031998C |Alpha-(tert-butyl aminomethyl)-3,4-dichloro benzyl¨ thioacetamide, process for preparing them and application |
06/12/1996 | CN1031995C Process for preparation of R-enantiomers of N-Propargyl-1-aminoindan compounds |
06/12/1996 | CN1031992C Quinone derivatives and pharmaceutical use |
06/11/1996 | US5525723 Inhibitors of angiotensin converting enzyme, neutral endopeptidase |
06/11/1996 | US5525652 Denture adhesive |
06/11/1996 | US5525635 Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof |
06/11/1996 | US5525632 Stilbene derivatives and pharmaceutical compositions containing them |
06/11/1996 | US5525631 Compositions of the ethyl ester of L-DOPA |
06/11/1996 | US5525630 Treatment for carbon monoxide poisoning |
06/11/1996 | US5525629 Inhibition of cytokine production |
06/11/1996 | US5525627 Esters of acyl carnitines with long-chain aliphatic alcohols and pharmaceutical compositions containing same having antimycotic activity |
06/11/1996 | US5525626 Treating susceptible human malignant tumors with 7-hydroxy-1,2-benzopyrone |
06/11/1996 | US5525625 2-(2-Amino-3-methoxyphenyl)-4-oxo-4H-[1]benzopyran for treating proliferative disorders |
06/11/1996 | US5525624 A 3-benzoyl,4-oxyphenylbenzothiophene compound |
06/11/1996 | US5525619 Inhibitors of monoamine oxidase b |
06/11/1996 | US5525618 Method of treating bone disease with pyridine, carboxamide and carboxylic derivatives |
06/11/1996 | US5525616 Subjecting cells to n-alkyl derivative of 1,5-dideoxy-1,5-imino-d-glucitol |
06/11/1996 | US5525614 Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin II receptor antagonist properties |
06/11/1996 | US5525613 Covalently coupled benzoylecgonine ecgonine and ecgonidine |
06/11/1996 | US5525612 Antiviral pharmaceutical composition |
06/11/1996 | US5525611 Antitumor agent, bactericides, viricides |
06/11/1996 | US5525609 Alkaloids from Mappia foetida, the use thereof and formulations containing them |
06/11/1996 | US5525608 17b-aryl-4-aza-steroid derivatives useful as 5-alpha-reductase inhibitors |
06/11/1996 | US5525606 Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines |
06/11/1996 | US5525605 Remedy for inflammatory intestinal diseases |
06/11/1996 | US5525604 4-aminopyrimidine derivatives |
06/11/1996 | US5525603 Mixture of 2,4-dihydroxypyridine compound and oxonic acidadministered with tegafur; side-effect reduction |
06/11/1996 | US5525602 Method of using 4-amino 6-substituted mycophenolic acid and derivatives |
06/11/1996 | US5525601 Administering calcium channel blocking agent to alleviate ocular surface pain in mammalian eye |